Provided by Tiger Trade Technology Pte. Ltd.

PEGBIO CO-B

5.895
-0.395-6.28%
Volume:8.31M
Turnover:50.21M
Market Cap:2.30B
PE:-10.72
High:6.280
Open:6.010
Low:5.885
Close:6.290
52wk High:77.000
52wk Low:4.940
Shares:391.00M
HK Float Shares:386.00M
Volume Ratio:0.71
T/O Rate:2.15%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.550
ROE:-82.42%
ROA:-31.46%
PB:4.40
PE(LYR):-10.72
PS:-509.82

Loading ...

Alibaba Health Says it Signed Strategic Cooperation with Tenry Pharmaceutical and Pegbio on Glp-1ra Drug

THOMSON REUTERS
·
Jul 17

PegBio, Tengrui Pharma, and Ali Health Forge Strategic Alliance to Accelerate Commercialization and Market Expansion of Patacon

Stock News
·
Jul 17

Movement Alert|PegBio Intraday Decline 8.04%, Rani Therapeutics Catalyst Fading Amid Broad Biotech Sector Selloff

Market Focus
·
Jul 17

Movement Alert|PegBio Pharma-B Rises 8.78% in Regular Trading, Technical Rebound After Prior Session Pullback With Rani Collaboration Catalyst Intact

Market Focus
·
Jul 15

Movement Alert|PegBio Intraday Decline 8.11%, Profit-Taking Emerges After Rani Therapeutics Partnership Rally

Market Focus
·
Jul 14

Movement Alert|PegBio Rises 8.42% in Regular Trading, Rani Therapeutics Oral Delivery Partnership Continues to Fuel Market Enthusiasm

Market Focus
·
Jul 13

Movement Alert|PegBio Rises 38.16% in Regular Trading, Partners with Rani Therapeutics to Advance Oral Delivery of Metabolic Assets

Market Focus
·
Jul 10

PEGBIO Shares Surge Over 21% on Oral Delivery Collaboration with Rani Therapeutics

Stock News
·
Jul 10

PegBio Partners with Rani: Oral Delivery Platform Opens Global Revaluation Path for Next-Generation Metabolic Assets

Stock News
·
Jul 10

Pegbio Co - Enters Mou with Nasdaq-listed Rani Therapeutics

THOMSON REUTERS
·
Jul 10

Pegbio Co - Collaboration to Advance Oral Delivery of Multiple Metabolic Assets

THOMSON REUTERS
·
Jul 10

Rani Therapeutics Partners with Pegbio to Develop Oral Obesity Drug Candidates

Reuters
·
Jul 10

PEGBIO Shares Surge on Positive Progress for Diabetes Drug in National Reimbursement Review

Stock News
·
Jul 02

Movement Alert|PegBio-B Falls 8.3% in Regular Trading, Continued Volatility After H-Share Full Circulation Completion

Market Focus
·
Jun 30

PegBio’s Visepegenatide Injection Clears Preliminary Hurdle for 2026 China NRDL Inclusion

Bulletin Express
·
Jun 29

PEGBIO's Key Drug Vipenatide Injection Clears Initial Review for 2026 National Reimbursement List

Stock News
·
Jun 29

Movement Alert|PegBio Rises 17.94% in Regular Trading, Stock Rebounds from Historic Low After H-Share Full Circulation Selloff

Market Focus
·
Jun 29

PegBio Completes H-Share Full Circulation

MT Newswires Live
·
Jun 26

Movement Alert|PegBio Pharmaceutical-B Falls 8.19% in Regular Trading, H-Share Full Circulation Completed with Over 100 Million Shares Newly Listed

Market Focus
·
Jun 26

PEGBIO CO-B Completes Full H-Share Conversion for Trading

Deep News
·
Jun 26